Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
- T. Hoffmann, P. Glasziou, +13 authors S. Michie
- Medicine
- BMJ : British Medical Journal
- 7 March 2014
Without a complete published description of interventions, clinicians and patients cannot reliably implement interventions that are shown to be useful, and other researchers cannot replicate or build… Expand
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- J. Sterne, M. Hernán, +32 authors J. Higgins
- Medicine
- British Medical Journal
- 12 October 2016
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their… Expand
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
- I. Boutron, D. Moher, D. Altman, K. Schulz, P. Ravaud
- Medicine
- Annals of internal medicine
- 19 February 2008
Adequate reporting of randomized, controlled trials (RCTs) is necessary to allow accurate critical appraisal of the validity and applicability of the results. The CONSORT (Consolidated Standards of… Expand
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- B. Hutton, G. Salanti, +14 authors D. Moher
- Medicine
- Annals of Internal Medicine
- 2 June 2015
Systematic reviews and meta-analyses are fundamental tools for the generation of reliable summaries of health care information for clinicians, decision makers, and patients. Systematic reviews… Expand
RoB 2: a revised tool for assessing risk of bias in randomised trials
- J. Sterne, J. Savović, +25 authors J. Higgins
- Computer Science, Medicine
- BMJ
- 28 August 2019
TLDR
A revised tool for assessing risk of bias in randomized trials
- J. Higgins, J. Sterne, +5 authors S. Eldridge
- Medicine
- 2016
- 629
- 31
Comparison of registered and published primary outcomes in randomized controlled trials.
- S. Mathieu, I. Boutron, D. Moher, D. Altman, P. Ravaud
- Medicine
- JAMA
- 2 September 2009
CONTEXT
As of 2005, the International Committee of Medical Journal Editors required investigators to register their trials prior to participant enrollment as a precondition for publishing the trial's… Expand
Reducing waste from incomplete or unusable reports of biomedical research
- P. Glasziou, D. Altman, P. Bossuyt, I. Boutron, E. Wager
- Medicine
- The Lancet
- 18 January 2014
Research publication can both communicate and miscommunicate. Unless research is adequately reported, the time and resources invested in the conduct of research is wasted. Reporting guidelines such… Expand
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.
- I. Boutron, S. Dutton, P. Ravaud, D. Altman
- Medicine
- JAMA
- 26 May 2010
CONTEXT
Previous studies indicate that the interpretation of trial results can be distorted by authors of published reports.
OBJECTIVE
To identify the nature and frequency of distorted presentation… Expand
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
- I. Boutron, D. Moher, D. Altman, K. Schulz, P. Ravaud
- Medicine
- Annals of internal medicine
- 19 February 2008
BACKGROUND
The conduct of randomized, controlled trials of nonpharmacologic treatments presents specific challenges that are not adequately addressed in trial reports.
OBJECTIVE
To develop an… Expand